M. Martinot

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19

Thomas Hueso, Cécile Pouderoux, Hélène Péré et al. · Blood · 2020 · 297 citations · Full text

Role of Comorbidity in Mortality Related to <i>Staphylococcus aureus</i> Bacteremia: A Prospective Study Using the Charlson Weighted Index of Comorbidity

O. Lesens, Cédric Methlin, Yves Hansmann et al. · Infection Control and Hospital Epidemiology · 2003 · 149 citations

Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019

M. Martinot, Aude Jary, Samira Fafi‐Kremer et al. · Clinical Infectious Diseases · 2020 · 119 citations · Full text

Viral Evolution, Viral Persistence, Viral Polymerase Structure +13

Babesiosis in Immunocompetent Patients, Europe

M. Martinot, M. Mohseni Zadeh, Yves Hansmann et al. · Emerging infectious diseases · 2010 · 104 citations · Full text

Parasitic Disease, Healthy Patients, Allergy +10